Literature DB >> 31343126

The impact of thyroid function on the occurrence of metabolic syndrome in obese children and adolescents.

Anna Ruszała1,2, Małgorzata Wójcik1,2, Jerzy B Starzyk1,2.   

Abstract

INTRODUCTION: Thyroid axis abnormalities are common in obese patients. Their contribution in the development of metabolic obesity complications remains unclear.
AIM OF STUDY: To assess the influence of thyroid axis dysfunction on the occurrence of metabolic obesity complications.
MATERIAL AND METHODS: A cross-sectional review of the thyroid function in 100 obese patients (59 girls and 41 boys, mean age 13.5 years) with alimentary obe-sity (mean standardised body mass index [BMI SDS] in boys 4.175 and girls 4.723) complicated by metabolic syndrome (MS) diag-nosed on the basis of the IDF 2006 criteria (MS, 25 patients) and uncomplicated (75 patients). TSH, fT4, fT3 thyroid peroxidase anti-bodies (TPOAb), and thyroglobulin antibodies (TGAb) were assessed in a single fasting blood sample.
RESULTS: There was no case of overt thyroid disease within the whole analysed group. There were no significant differences in mean TSH, fT4, and fT3 levels in patients with and without MS (2.7 µIU/ml vs. 3.0 µIU/ml, 14.5 vs. 14.0 pmol/l, and 5.6 vs. 6.2, respectively; p > 0.05). In the MS group only two patients (8%) presented with a TSH level above the upper limit of the normal range; in the group without MS elevated TSH was noticed in 18 (24%) patients. The maximal value of TSH (10.44 µIU/ml) was noticed in one boy without MS. Positive TPOAb and/or TGAb were present in 11% of all patients: two patients (8%) with MS and nine (12%) without MS.
CONCLUSIONS: Isolated increased TSH level is common in obese adolescents, although there is no correlation between TSH, fT3, and fT4 levels and BMI SDS value. Isolated increased TSH level is not associated with the occurrence of MS in obese adolescents. The occurrence of asymptomatic autoimmune thyroiditis (AITD) in obese adolescents is more common than in the general population.

Entities:  

Keywords:  metabolic syndrome; thyroid; obesity

Year:  2019        PMID: 31343126     DOI: 10.5114/pedm.2019.84705

Source DB:  PubMed          Journal:  Pediatr Endocrinol Diabetes Metab        ISSN: 2083-8441


  3 in total

1.  Association between decreased thyroid stimulating hormone and hyperuricemia in type 2 diabetic patients with early-stage diabetic kidney disease.

Authors:  Xiaomeng Feng; Jing Huang; Yan Peng; Yuan Xu
Journal:  BMC Endocr Disord       Date:  2021-01-06       Impact factor: 2.763

2.  Leptin Does Not Influence TSH Levels in Obese Short Children.

Authors:  Katarzyna Adamczewska; Zbigniew Adamczewski; Andrzej Lewiński; Renata Stawerska
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-24       Impact factor: 5.555

3.  Does Hashimoto's Thyroiditis Increase the Risk of Cardiovascular Disease in Young Type 1 Diabetic Patients?

Authors:  Barbara Głowinska-Olszewska; Hanna Borysewicz-Sańczyk; Beata Sawicka; Bożenna Klonowska; Dorota Charemska; Beata Żelazowska-Rutkowska; Artur Bossowski
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-24       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.